Clinical trial
The Effect of Salmeterol on Eosinophil (EOS) Function
NCT00214019 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214019 |
|---|---|
| Title | The Effect of Salmeterol on Eosinophil (EOS) Function |
| Official title | The Effect of Salmeterol on Eosinophil (EOS) Function |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Allergic Asthma |
| Intervention type | Drug |
| Interventions | salmeterol, Fluticasone, Placebo |
| Enrollment | 36 |
| Start date | Nov 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: